It is my understanding after meeting with Tony Weber about 2 months ago that the only extra funding that would be needed would be to progress Berenice in the pre feso study.
They are very aware of issuing cheap capital, remember they are significant shareholders themselves, also AMED would not be agreeable to issuing capital under their price of 14 cents.
price target 20c, page-10
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)